Don't want ads? Subscribe or login now.

DocGo Investors Seek OK Of $12.5M Deal Over Ex-CEO Claims

By Sydney Price · November 13, 2025, 3:10 PM EST

Investors of mobile medical provider DocGo have asked a New York federal court to grant preliminary approval of their $12.5 million settlement of claims that the company deceived stockholders before a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

Naclerio v. DocGo Inc. et al

Case Number

1:23-cv-09476

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

October 27, 2023

Recent Articles By Sydney

November 10, 2025
Acadia Healthcare Inks Investor Settlement Days Before Trial
November 07, 2025
Sleep Apnea Device Co. Investor Says Rollout Was Botched
October 31, 2025
Obesity Drugmaker Escapes Clinical Trial Securities Suit
October 10, 2025
ATyr Pharma Faces Investor Suit Over Failed Drug Trial
October 10, 2025
Pharma Co. Escapes Suit Over Ex-CEO's Alleged Misconduct
October 07, 2025
Biogen Says Investors Can't Expand Alzheimer's Drug Suit
September 26, 2025
Semler Scientific, Bard To Pay $37M To End FCA Claims
September 24, 2025
UnitedHealth Fights Investor Suit Over DOJ's Merger Probe
September 23, 2025
Axsome Settles Investors' Drug Approval Suit For $7.8M
September 10, 2025
DexCom Beats Most Of Investors' Diabetes Device Sales Suit